Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Understanding how GLP1R signalling protects the heart and blood vessels will optimize the therapeutic use and development of next-generation GLP1-based therapies with improved cardiovascular safety
Anuradha D, Reddy KV, Kumar TC, Neeraja S, Reddy PR, Reddanna P
Supplies You Need Before You Start Getting the right supplies prevents improvisation at the bench, which is where errors happen
Gao L, Lee BW, Chawla M, Kim J, Huo L, Du L, et al
ABSTRACT INTRODUCTION GLUCAGON GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE GLUCAGON-LIKE PEPTIDE-1 DUAL GLUCAGON/GLUCAGON-LIKE PEPTIDE-1 RECEPTOR CO-AGONISTS DUAL GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE/GLUCAGON-LIKE PEPTIDE-1 RECEPTOR CO-AGONISTS TRIPLE GLUCAGON-LIKE PEPTIDE-1/GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE/GLUCAGON RECEPTOR TRIAGONISTS CONCLUSIONS Article information References ABSTRACT Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide
& Xiong, W
US$ 22.78
US$ 28.95
US$ 27.72
US$ 21.87
